These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 25518388)
1. [Prevention of relapse of neuromyelitis optica (NMO)]. Nomura K Nihon Rinsho; 2014 Nov; 72(11):2023-30. PubMed ID: 25518388 [TBL] [Abstract][Full Text] [Related]
2. [Treatment of neuromyelitis optica]. Nomura K Nihon Rinsho; 2013 May; 71(5):829-38. PubMed ID: 23777090 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of effect of empirical attack-preventive immunotherapies in neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis. Ma J; Yu H; Wang H; Zhang X; Feng K J Neuroimmunol; 2022 Feb; 363():577790. PubMed ID: 34959021 [TBL] [Abstract][Full Text] [Related]
4. [Treatment and clinical management of patients with neuromyelitis optica and anti-aquaporin 4 antibody]. Ochi H Brain Nerve; 2010 Sep; 62(9):945-52. PubMed ID: 20844305 [TBL] [Abstract][Full Text] [Related]
5. Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy. Mealy MA; Wingerchuk DM; Palace J; Greenberg BM; Levy M JAMA Neurol; 2014 Mar; 71(3):324-30. PubMed ID: 24445513 [TBL] [Abstract][Full Text] [Related]